EPHX2 and colorectal carcinoma: Due to the involvement of mPGES‐1 and sEH in human CRC, 1f, 2b, 2c, and 2d were tested on the HCT‐116 CRC cell line for anticancer activity, disclosing significative antiproliferative effects, which highlight their potential as new candidate therapeutic agents.